BRAF-activated ARSI suppressed EREG-mediated ferroptosis to promote BRAFV600E (mutant) papillary thyroid carcinoma progression and sorafenib resistance
Year: 2024
Type: article
Abstract: PTC patients.
DOI: 10.7150/ijbs.99423
Authors: Xing Chen, Xing Chen, Xiang Chen, Xiang Chen, Wenjun Xie, Hua Ge, Hongyan He, Ailong Zhang, Junjie Zheng
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,337
OpenAlex ID: W4405256139
